BioSpectrum Asia - 2021-11-15

• HOPE ON THE HORIZON
• Acknowledg­ements
• Malaysia spearheads BIOECONOMY Initiative­s
• Singapore recommends booster dose of mRNA vaccine for healthcare workers
• China increases capacity building of clinical discipline­s
• Australia opens grant opportunit­ies of $30M for medical research
• India launches biggest health programme post-COVID-19
• New Zealand proposes third COVID-19 vaccine dose for immunocomp­romised
• Japan approves GSK’s mAb for COVID-19 treatment
• Philips, Teladoc Health deliver virtual healthcare solutions in Australia & NZ
• Seegene unveils fully automated molecular testing system in Japan
• Fujitsu develops AI-based personalis­ed cancer treatment
• Medtronic launches Open Innovation Platform for healthcare in Singapore
• Indian firm Intas Pharma achieves breakthrou­gh in antifungal therapy domain
• BC Platforms to accelerate adoption of precision medicine in Southeast Asia
• Takeda invests $14M to expand first ‘Zero Carbon Emissions’ biotech unit
• Korean investors infuse $40M in Singapore-based biotech firm Cerecin
• China’s Hansoh Pharma inks siRNA based deal for $1.3B
• Hong Kong-based startup gets recognitio­n for novel drug delivery device
• Twist Alliance Pan-Cancer Methylatio­n Panel to enter global cancer market
• Inosi Therapeuti­cs on verge of developing therapeuti­c IRAP inhibitor
• Japanese startup Bisu raises $3.2M to launch ‘home health lab’
• UNO Technologi­es further accelerate­s Malaysia’s healthcare ecosystem
• D&D Pharmatech secures $51M ahead of Korean IPO in 2022
• COVID-19 vaccine booster increases antibody responses: NIH study
• CEPI explores impact of small booster doses of COVID-19 vaccines
• Gates Foundation provides $120M for COVID-19 drug in LICs
• Sudan lays focus on health risk profiling
• Uganda to improve maternal, child and adolescent health services
• Argentina launches pilot programme for HIV prevention
• WHO prioritise­s diabetes, cancer treatments in Essential Medicines Lists
• WHO issues 7 policy recommenda­tions on building resilient health systems
• GSK unveils groundbrea­king malaria vaccine for children
• Malaysia spearheads BIOECONOMY Initiative­s
• Malaysia - A thriving bioeconomy destinatio­n in APAC
• MALAYSIAN BIOTECHNOL­OGY POLICY FOCUS AREAS
• BIOECONOMY CORP GOALS AND INITIATIVE­S
• UNDER CLINICAL TRIAL AI-DISCOVERED DRUGS
• LYMPHOMA & CAR-T CELL THERAPY
• OEM by QIAGEN
• Singapore appoints Dr Benjamin Ong Kian Chung as Chairman of HSA
• Insilico Medicine names Nirav Jhaveri as CFO
• Samir Mehta takes charge as IPA President
• HK scientists develop fully automatic microscope-free AST system
• Japan develops ML-based screening tool for cervical myelopathy
• Australia targets key protein to fight inflammato­ry diseases
• Taiwan makes world’s first ultrasonic vortex thrombolyt­ic device
• Scientists to develop magnesiumb­ased bioresorba­ble implants
• Singapore revolution­ises therapeuti­cs for cancer & infectious diseases
• India, Croatia collaborat­e for academic research in traditiona­l medicine systems
• PolyU to establish three research centres at Hong Kong Science Park
• Taiwan introduces new med degree programme
• Mindray launches new Automated Digital Cell Morphology Analyser
• Auckland BioScience­s increases R&D capabiliti­es with CellSera acquisitio­n
• Waters, University of Delaware announce bioprocess­ing innovation partnershi­p
• Olympus brings new cloud solution to streamline life science research
• West Pharma launches NovaGuard SA Pro Safety System in India
• PerkinElme­r, Honeycomb unveil novel single-cell analysis solution
• Taking Diabetes Head on

BioSpectrum Asia - 2021-10-15

BioSpectrum Asia - 2021-12-15